Factors influencing perinatal outcomes in women with preterm preeclampsia: A secondary analysis of the PHOENIX trial.
Sign Up to like & getrecommendations! Published in 2021 at "Pregnancy hypertension"
DOI: 10.1016/j.preghy.2021.10.002
Abstract: This secondary analysis of the PHOENIX trial (evaluating planned delivery against expectant management in late preterm preeclampsia) demonstrates that in women who started induction of labour, 63% of women delivered vaginally (56% at 34 weeks' gestation).… read more here.
Keywords: preterm preeclampsia; phoenix trial; analysis phoenix; secondary analysis ... See more keywords
Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial
Sign Up to like & getrecommendations! Published in 2023 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022009389
Abstract: Key Points • In the PHOENIX trial, the addition of ibrutinib to R-CHOP did not improve the survival of patients with previously untreated non-GCB DLBCL.• This study identified a patient subset with high BCL2/MYC coexpression… read more here.
Keywords: chop; dlbcl; bcl2 myc; clinical impact ... See more keywords